SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-24-004309
Filing Date
2024-06-14
Accepted
2024-06-14 16:34:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 OLEMA PHARMACEUTICALS INC. p24-2172sc13g.htm SC 13G 68433
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p24-2172exhibit99.htm EX-99 5932
  Complete submission text file 0000902664-24-004309.txt   75895
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Subject) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91849 | Film No.: 241045415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)